Company Filing History:
1 out of 88 
1 out of 1 Years Active: 1989-1998
Title: The Innovative Contributions of Farid Hamedi-Sangsari
Introduction
Farid Hamedi-Sangsari, an accomplished inventor based in Lyons, France, has made significant strides in the fields of chemistry and pharmacology. With two patents to his name, his work focuses on compounds with remarkable therapeutic properties, showcasing his innovative spirit and dedication to improving human health.
Latest Patents
Hamedi-Sangsari's latest patents encompass groundbreaking research in medicinal chemistry. The first patent details "Compounds having anti-inflammatory and anti-viral activity." This new family of compounds features both linear and cyclic formulas and has demonstrated efficacy in inhibiting or suppressing viruses, including those exhibiting retroviral replication, such as HIV. The inventive compositions can be used alone or in combination with reverse transcriptase inhibitors, resulting in an additive or synergistic effect to treat viral infections effectively.
The second patent outlines a "Process for the preparation of glyoxal monoacetal." This innovative process involves reacting glyoxal in the presence of an acid catalyst with an excess of the corresponding alcohol, yielding products beneficial for further pharmaceutical developments. Among these novel products is 2,2-diallyloxy ethanal, showcasing Hamedi-Sangsari's ability to advance the chemistry of glyoxals and their derivatives.
Career Highlights
Throughout his career, Hamedi-Sangsari has worked with prominent companies such as Société Française Hoechst and Compagnie de Développement Aguettant S.A. His contributions in these roles have been pivotal in advancing research and development in the pharmaceutical industry, enabling the creation of new solutions for significant health challenges.
Collaborations
Collaboration has been an essential aspect of Hamedi-Sangsari's work. He has collaborated with accomplished professionals, including Alain Blanc and Francine J. Chastrette, combining their expertise to enhance research outcomes capable of leading to innovative solutions in medicine and chemistry.
Conclusion
Farid Hamedi-Sangsari stands out as a prolific inventor whose research reflects a commitment to addressing critical health issues through innovation. His patents on anti-viral and anti-inflammatory compounds, along with advances in glyoxal chemistry, are a testament to his role as a leader in scientific innovation. His collaborative efforts and industry experience continue to inspire advancements that could significantly impact healthcare and therapeutic practices in the future.